France - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)
Since 2014, France Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) increased 1.9% year on year. In 2019, the country was ranked number 5 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) with €412.39 Per Capita. France is overtaken by Belgium, which was number 4 with €420.62 Per Capita and is followed by Luxembourg with €398.82 Per Capita. Switzerland topped the ranking with €665.57 Per Capita in 2019, that is a growth of 3.2% versus 2018. Switzerland recorded the best 5 years average growth at +5.4% per year, while Portugal was the worst growing country at -12.9% per year.
Date | Euros Per Capita |
---|---|
2019 | 412.39 |
2018 | 409.89 |
2017 | 404.65 |
2016 | 398.59 |
2015 | 371.03 |
How does France rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)?
# | 23 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Switzerland
|
665.57 | 2019 | +3.1 % | +5.3 % | View data | |
2 |
#2
Germany
|
524.79 | 2019 | +2.3 % | +3.0 % | View data | |
4 |
#4
Belgium
|
420.62 | 2019 | +0.4 % | +3.9 % | View data | |
5 |
#5
France
|
412.39 | 2019 | +0.6 % | +1.9 % | View data | |
6 |
#6
Luxembourg
|
398.82 | 2019 | -0.2 % | +1.2 % | View data |